Call Us Contact Us
+44 1494 818 000     Online Enquiry
Lines open
Monday to Thursday
08:30 to 18:00
Friday
08:30 to 17:30
Pharmaceutical | Medical Devices | Scientific | Consumer Healthcare | Dental | Animal Health
Healthcare Communications | Pharmaceutical Executive | Medical Executive | Tech PR | Scientific Executive
         
Latest Jobs
Exclusive vacancies may not be shown here, please contact Liam on +44 1494 818 027 or liam@zenopa.com for more information.
Have you registered?
Once you register you can see additional job details, save jobs, track your applications and manage e-lert preferences.

Register now
Liam Whelan
Senior Account Manager
liam@zenopa.com
+44 1494 818 027

Testimonials
Zenopa has been a massive help in assisting me to make the jump from doing a PhD in academia into the world of medical writing, and I have now been able to land the perfect job.
Davinder, 2014

Agilent Technologies announces appointment of George Scangos

24 March 2014 14:05 in Scientific Company News


Agilent Technologies announces appointment of George ScangosAgilent Technologies has announced George Scangos, chief executive officer and director of Biogen Idec, has been appointed to its board of directors.

He will take his place from September and it will be the latest step in a distinguished career in the sector. Prior to working at Biogen, Dr Scangos served as president and chief executive officer at Exelixis Inc and was previously president of Bayer Biotechnology.

"I am delighted to welcome Dr Scangos to the board," said James Cullen, Agilent chairman. "He has an extraordinary combination of biotechnology and business expertise along with insights that come from running a large successful global pharma company."

Agilent's strong history of innovation and integrity was one of the reasons that Dr Scangos was attracted to the role. He added that he looks forward to contributing to its future direction and growth. 

Dr Scangos replaces David Lawrence, who is retiring from the Agilent board after more than a decade of service.ADNFCR-8000103-ID-801705934-ADNFCR

Other news stories from 24/03/2014

Related news

Read more in the Zenopa News Archive

How this news is generated

Story collated for Zenopa by the Axonn News Agency



                    
© Copyright 2014 Zenopa Ltd